Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | ACACB | O00763 | 1/20 | 0.42 |
| ▸ | ACACA | Q13085 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4920071 | 1.00 | ACE2 (0.46) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL6667219 | 0.96 | ACE2 (0.42) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL29100228 | 0.96 | ACE2 (0.42) | ACE2GPR84FFAR1MAPTLCK | |
| Ethylene Glycol SCHEMBL8083787 | 0.95 | ACE2 (0.42) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL517722 | 0.92 | FFAR4 (0.56) | GPR84FFAR1MAPTPPARDBLM | |
| Glycerin SCHEMBL1091506 | 0.92 | GPR84 (0.45) | ACE2GPR84FFAR1MAPTFFAR4 | |
| SCHEMBL15281992 | 0.90 | FFAR4 (0.53) | GPR84FFAR1MAPTPPARDBLM | |
| SCHEMBL3251856 | 0.87 | THRA (0.38) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL16335066 | 0.84 | HSPD1 (0.53) | ACE2GPR84FFAR1MAPTLCK | |
| SCHEMBL29167335 | 0.84 | ACE2 (0.44) | ACE2GPR84FFAR1MAPTLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113226254-B | Oil-in-water emulsion cosmetic containing retinol | 株式会社资生堂 | 2024-02-23 | — | — | CN | claimed |
| EP-3006547-B1 | FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED | SHISEIDO CO LTD (JP) | 2019-10-30 | — | — | EP | claimed |
| EP-1466586-B1 | Water-in-oil emulsion preparation for external use on skin | NISSHIN OILLIO GROUP LTD (JP) | 2011-10-12 | — | — | EP | claimed |
| WO-2024142911-A1 | WATER-IN-OIL EMULSION COSMETIC | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| CN-118019518-A | Water-in-oil type emulsified cosmetic | 株式会社资生堂 | 2024-05-10 | — | — | CN | disclosed |
| CN-115175662-B | Cosmetic product | 信越化学工业株式会社 | 2024-05-03 | — | — | CN | disclosed |
| CN-112996473-B | Powder dispersion composition and dispersion method thereof | 株式会社资生堂 | 2024-04-05 | — | — | CN | disclosed |
| CN-113693965-B | External preparation for skin for improving wrinkles | 宝丽化成工业有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-114040746-B | Oil-in-water type cleansing cosmetic | 陶氏东丽株式会社 | 2024-02-27 | — | — | CN | disclosed |
| CN-113710226-B | Cosmetic material | 陶氏东丽株式会社 | 2024-02-27 | — | — | CN | disclosed |
| CN-113226254-B | Oil-in-water emulsion cosmetic containing retinol | 株式会社资生堂 | 2024-02-23 | — | — | CN | disclosed |
| US-20080031906-A1 | Cosmetic Composition and Method for Producing the Same | HAKUTO CO., LTD. (JP) | 2008-02-07 | — | — | US | disclosed |
| EP-1330999-B1 | MELANOGENESIS INHIBITORS AND WHITENING AGENTS COMPRISING ERGOSTEROL DERIVATIVE AND COMPOSITIONS CONTAINING ERGOSTEROL DERIVATIVE | SAKAMOTO BIO CO LTD (JP) | 2007-12-26 | — | — | EP | disclosed |
| EP-1820538-A1 | COSMETICS AND PROCESS FOR PRODUCTION THEREOF | Hakuto Co., Ltd (JP) | 2007-08-22 | — | — | EP | disclosed |
| EP-1500385-A1 | METHOD OF FOAM STABILIZATION FOR FOAM COSMETIC | Hakuto Co., Ltd (JP) | 2005-01-26 | — | — | EP | disclosed |
| EP-1486193-A1 | METHOD OF STABILIZING SILICONE OIL-CONTAINING COSMETIC COMPOSITION | Hakuto Co., Ltd (JP) | 2004-12-15 | — | — | EP | disclosed |
| WO-2004062635-A1 | COMPOSITIONS FOR SKIN LIGHTENING COMPRISING BIS-PANTOYL-CYSTAMINE | DSM IP ASSETS B.V. (NL) | 2004-07-29 | — | — | WO | disclosed |
| WO-2004062633-A1 | HAIR CARE COMPOSITIONS COMPRISING BIS - PANTOYL - CYSTAMINE OR A DERIVATIVE THEREOF | DSM IP ASSETS B.V. (NL) | 2004-07-29 | — | — | WO | disclosed |
| US-20030190299-A1 | Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative | SAKAMOTO BIO CO., LTD. (JP) | 2003-10-09 | — | — | US | disclosed |
| EP-1330999-A1 | MELANOGENESIS INHIBITORS AND WHITENING AGENTS COMPRISING ERGOSTEROL DERIVATIVE AND COMPOSITIONS CONTAINING ERGOSTEROL DERIVATIVE | Sakamoto Bio Co. Ltd. (JP) | 2003-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080031906-A1 | Cosmetic Composition and Method for Producing the Same | LIPA, CUTA, PLIN3 | ACE2 4879/4885GPR84 3473/4885FFAR1 2445/4885 |
| US-20030190299-A1 | Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative | CYP51A1, TYR, CYP46A1 | ACE2 2752/4885GPR84 1197/4885FFAR1 999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.